Two receptors are involved in the central functions of kynurenic acid under an acute stress in neonatal chicks

J. Yoshida, A. Shigemura, Y. Ogino, D. M. Denbow, Mitsuhiro Furuse

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Intracerebroventricular (i.c.v.) injection of kynurenic acid (KYNA) had sedative and hypnotic effects during stress in neonatal chicks. However, its mechanism has not been clarified. KYNA is an endogenous antagonist of the α7 nicotinic acetylcholine (α7nACh) receptor and N-methyl-. d-aspartate (NMDA) receptor. Therefore, this study clarified the mechanism of sedative and hypnotic effects of KYNA in the brain during an acute stress. In Experiment 1, to investigate the relationship between KYNA and the α7nACh receptor, KYNA was injected i.c.v. with galantamine, an agonist of the allosteric potentiating site of the α7nACh receptor. Galantamine did not attenuate the effect of KYNA, but higher levels of galantamine caused harmful effects. In Experiment 2, the role of the NMDA receptor was investigated using the NMDA receptor antagonist (+)-MK-801, d-serine which has high affinity to a co-agonist glycine site at the NMDA receptors, NMDA as the NMDA receptor agonist, and 2,3-pyridinedicarboxylic acid (QUIN), an agonist of the NMDA receptor subgroup containing the subunits NR2A and NR2B. The behavioral changes following KYNA were partially attenuated by QUIN alone. In conclusion, we suggest that KYNA functioned via the simultaneous inhibition of the α7nACh receptor and NMDA receptor subgroup containing the subunits NR2A and NR2B.

Original languageEnglish
Pages (from-to)194-200
Number of pages7
JournalNeuroscience
Volume248
DOIs
Publication statusPublished - Sep 17 2013

Fingerprint

Kynurenic Acid
N-Methyl-D-Aspartate Receptors
Nicotinic Receptors
Galantamine
Hypnotics and Sedatives
Allosteric Site
Quinolinic Acid
Dizocilpine Maleate
N-Methylaspartate
Glycine
Serine
Injections
Brain

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Two receptors are involved in the central functions of kynurenic acid under an acute stress in neonatal chicks. / Yoshida, J.; Shigemura, A.; Ogino, Y.; Denbow, D. M.; Furuse, Mitsuhiro.

In: Neuroscience, Vol. 248, 17.09.2013, p. 194-200.

Research output: Contribution to journalArticle

Yoshida, J. ; Shigemura, A. ; Ogino, Y. ; Denbow, D. M. ; Furuse, Mitsuhiro. / Two receptors are involved in the central functions of kynurenic acid under an acute stress in neonatal chicks. In: Neuroscience. 2013 ; Vol. 248. pp. 194-200.
@article{d3afe932716b4feea3522cf0f0d6b329,
title = "Two receptors are involved in the central functions of kynurenic acid under an acute stress in neonatal chicks",
abstract = "Intracerebroventricular (i.c.v.) injection of kynurenic acid (KYNA) had sedative and hypnotic effects during stress in neonatal chicks. However, its mechanism has not been clarified. KYNA is an endogenous antagonist of the α7 nicotinic acetylcholine (α7nACh) receptor and N-methyl-. d-aspartate (NMDA) receptor. Therefore, this study clarified the mechanism of sedative and hypnotic effects of KYNA in the brain during an acute stress. In Experiment 1, to investigate the relationship between KYNA and the α7nACh receptor, KYNA was injected i.c.v. with galantamine, an agonist of the allosteric potentiating site of the α7nACh receptor. Galantamine did not attenuate the effect of KYNA, but higher levels of galantamine caused harmful effects. In Experiment 2, the role of the NMDA receptor was investigated using the NMDA receptor antagonist (+)-MK-801, d-serine which has high affinity to a co-agonist glycine site at the NMDA receptors, NMDA as the NMDA receptor agonist, and 2,3-pyridinedicarboxylic acid (QUIN), an agonist of the NMDA receptor subgroup containing the subunits NR2A and NR2B. The behavioral changes following KYNA were partially attenuated by QUIN alone. In conclusion, we suggest that KYNA functioned via the simultaneous inhibition of the α7nACh receptor and NMDA receptor subgroup containing the subunits NR2A and NR2B.",
author = "J. Yoshida and A. Shigemura and Y. Ogino and Denbow, {D. M.} and Mitsuhiro Furuse",
year = "2013",
month = "9",
day = "17",
doi = "10.1016/j.neuroscience.2013.06.005",
language = "English",
volume = "248",
pages = "194--200",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Two receptors are involved in the central functions of kynurenic acid under an acute stress in neonatal chicks

AU - Yoshida, J.

AU - Shigemura, A.

AU - Ogino, Y.

AU - Denbow, D. M.

AU - Furuse, Mitsuhiro

PY - 2013/9/17

Y1 - 2013/9/17

N2 - Intracerebroventricular (i.c.v.) injection of kynurenic acid (KYNA) had sedative and hypnotic effects during stress in neonatal chicks. However, its mechanism has not been clarified. KYNA is an endogenous antagonist of the α7 nicotinic acetylcholine (α7nACh) receptor and N-methyl-. d-aspartate (NMDA) receptor. Therefore, this study clarified the mechanism of sedative and hypnotic effects of KYNA in the brain during an acute stress. In Experiment 1, to investigate the relationship between KYNA and the α7nACh receptor, KYNA was injected i.c.v. with galantamine, an agonist of the allosteric potentiating site of the α7nACh receptor. Galantamine did not attenuate the effect of KYNA, but higher levels of galantamine caused harmful effects. In Experiment 2, the role of the NMDA receptor was investigated using the NMDA receptor antagonist (+)-MK-801, d-serine which has high affinity to a co-agonist glycine site at the NMDA receptors, NMDA as the NMDA receptor agonist, and 2,3-pyridinedicarboxylic acid (QUIN), an agonist of the NMDA receptor subgroup containing the subunits NR2A and NR2B. The behavioral changes following KYNA were partially attenuated by QUIN alone. In conclusion, we suggest that KYNA functioned via the simultaneous inhibition of the α7nACh receptor and NMDA receptor subgroup containing the subunits NR2A and NR2B.

AB - Intracerebroventricular (i.c.v.) injection of kynurenic acid (KYNA) had sedative and hypnotic effects during stress in neonatal chicks. However, its mechanism has not been clarified. KYNA is an endogenous antagonist of the α7 nicotinic acetylcholine (α7nACh) receptor and N-methyl-. d-aspartate (NMDA) receptor. Therefore, this study clarified the mechanism of sedative and hypnotic effects of KYNA in the brain during an acute stress. In Experiment 1, to investigate the relationship between KYNA and the α7nACh receptor, KYNA was injected i.c.v. with galantamine, an agonist of the allosteric potentiating site of the α7nACh receptor. Galantamine did not attenuate the effect of KYNA, but higher levels of galantamine caused harmful effects. In Experiment 2, the role of the NMDA receptor was investigated using the NMDA receptor antagonist (+)-MK-801, d-serine which has high affinity to a co-agonist glycine site at the NMDA receptors, NMDA as the NMDA receptor agonist, and 2,3-pyridinedicarboxylic acid (QUIN), an agonist of the NMDA receptor subgroup containing the subunits NR2A and NR2B. The behavioral changes following KYNA were partially attenuated by QUIN alone. In conclusion, we suggest that KYNA functioned via the simultaneous inhibition of the α7nACh receptor and NMDA receptor subgroup containing the subunits NR2A and NR2B.

UR - http://www.scopus.com/inward/record.url?scp=84880367584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880367584&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2013.06.005

DO - 10.1016/j.neuroscience.2013.06.005

M3 - Article

VL - 248

SP - 194

EP - 200

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

ER -